Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News | ACC

TRILUMINATE Pivotal Trial Findings Reported at ACC.23/WCC Reveal Impact of Improved Tricuspid Valve Functioning

March 4, 2023 — Findings from the TRILUMINATE Pivotal Trial found no significant difference in survival or ...

March 04, 2023

Statistically significant reduction in the risk for the primary outcome on Day 27

News | Heart Failure

New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at ACC23

March 4, 2023 - Lexicon Pharmaceuticals, Inc. announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...

March 04, 2023

News | ACC

CLEAR Trial Reported at ACC23 Finds Bempedoic Acid Lowers LDL Cholesterol, Reduces Risk of Serious Cardiovascular Outcomes in Statin-Intolerant Patients

March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse ...

March 04, 2023

Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)

News | Structural Heart

New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation

March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a ...

March 04, 2023

iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference

News | ACC

Four New Studies Featuring Zio by iRhythm to be Presented at ACC.23/WCC

March 3, 2023 — iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions ...

March 03, 2023

Machine learning can be used to help clinicians with early diagnosis

News | Heart Failure

Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease

March 3, 2023 — Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart ...

March 03, 2023

News | FFR Technologies

CathWorks to Present Outcomes from International Real-World FFRangio Registry to be Presented at ACC 2023

March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...

March 03, 2023

Primary Results from RADIANCE II Trial Published in JAMA and Results of Pooled Analysis from Three RADIANCE Studies Published in JAMA Cardiology

News | Renal Denervation

ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

March 2, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that primary ...

March 02, 2023

Single Intra-Myocardial Intervention with Rexlemestrocel-L Reduced Cardiovascular Death, Myocardial Infarction or Stroke Over Mean Follow-Up of 30 Months in High-Risk Patients with Chronic Heart Failure

News | Ventricular Assist Devices (VAD)

DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology

March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...

March 01, 2023

Data from "Real-Time Atrial Appendage Assessment for LAAO-CLAAS Device Selection: Angiography vs TEE" was presented at Cardiovascular Research Technologies Conference (CRT)

News | Left Atrial Appendage (LAA) Occluders

Study Demonstrates Successful Device Size Selection When Assessing Left Atrial Appendage by Angiography Compared to TEE

February 27, 2023 — Conformal Medical, Inc. announced today the results from the CONFORMAL Early Feasibility Study (EFS) ...

February 27, 2023

Presentations on Additional REDUCE-IT Sub-Population, In-Vitro Data on EPA to Be Featured at the Congress

News | Pharmaceuticals

Amarin Corp. to Present New Data Evaluating Vascept/Vazkepa (Icosapent Ethyl) at ACC23/WCC

February 27, 2023 — Amarin Corporation plc announced that data evaluating the role of VASCEPA /VAZKEPA (icosapent ethyl) ...

February 27, 2023

Heart attacks (myocardial infarction (MI)) occur due to an acute complication of coronary artery disease and are a major cause of global mortality.

News | STEMI

Researchers Investigate Pre-clinical Model for Clinically Relevant Treatments for Heart Attacks

February 27, 2023 — CÚRAM SFI Research Centre for Medical Devices researchers have published in Nature Communications a ...

February 27, 2023

Featured presentation on the time to clinical benefit of sotagliflozin in people with worsening heart failure

News | Heart Failure

Abiomed at CRT 2023: Benefits of Impella-Supported High Risk PCI and Impella Innovation

February 24, 2023 — Abiomed, Inc., part of Johnson & Johnson MedTech[1], announced that results from a study on Impella ...

February 24, 2023

Data show IVC filter use led to few adverse events, even when used prophylactically

News | Interventional Radiology

New study demonstrates inferior vena cava (IVC) filters are safe and effective way to treat venous thromboembolism (VTE)

February 23, 2023 — Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep ...

February 23, 2023

News | Heart Failure

New Analyses of Sotagliflozin to be Presented at ACC23

February 23, 2023 — Lexicon Pharmaceuticals, Inc. announced the upcoming presentation of new analyses of results from ...

February 23, 2023